Jules Evans

1 week ago | journals.plos.org | Eirini K. Argyri |Jules Evans |David Luke

Citation: Argyri EK, Evans J, Luke D, Michael P, Michelle K, Rohani-Shukla C, et al. (2025) Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences. PLoS One 20(5): e0322501. https://doi.org/10.1371/journal.pone.0322501Editor: Michal Mahat-Shamir, Ariel University, ISRAELReceived: June 5, 2024; Accepted: March 21, 2025; Published: May 5, 2025Copyright: © 2025 Argyri et al.

2 weeks ago | ecstaticintegration.org | Jules Evans

The Global Psychedelic Survey launches today, in what will hopefully be the biggest ever survey. You can complete it in a range of languages at this link. Thanks!I often mention the psychedelic industry’s entity dilemma - people regularly encounter entities on psychedelics, how should they relate to them? What should guides be taught about them? What should the industry say about them to patients and regulators? So far, the psychedelic pharma industry has maintained an uneasy silence.

2 weeks ago | ecstaticintegration.org | Jules Evans

Ari Kuschnir is an LA-based creative media producer with an interest in psychedelic spirituality (among other topics). He bought and renovated a house in the Palisades and finally moved in to his dream home, only to see it severely damaged in the LA fires earlier this year. He tells me: ‘I had 30 minutes to pack one suitcase. It was interesting how little I actually needed.’ He also saw how quickly things can fall apart: ‘10am was a normal day in LA.

2 weeks ago | nytimes.com | Jules Evans

When the political scientist Rick Doblin founded an organization in the 1980s aimed at securing federal approval for the medical use of MDMA, also known as Ecstasy, his vision was nothing short of utopian. He thought the psychedelic drug, which can enhance feelings of love and social connection, would heal global trauma and usher in world peace. The psychedelic movement at that time was a grass-roots effort by hippies, students and bohemians.

2 weeks ago | ecstaticintegration.org | Jules Evans

Jonathan Lubecky (on the right in the photo above) is a former Marine who developed PTSD in the second Iraq war, and tried to take his own life five times in the subsequent years. He took part in a MAPS’ trial of MDMA therapy for PTSD in 2014, and his symptoms abated. He is a career lobbyist in Washington, working on many campaigns unrelated to psychedelics and, in 2018, he joined MAPS as its Veterans and Government Affairs Liason.